Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
polyunsaturated fatty acids (1 trial)
rosuvastatin (crestor) (1 trial)
valsartan (diovan) (1 trial)
Atrial Fibrillation (Phase 3)
Heart Failure (Phase 3)
Recurrence (Phase 3)
Trials (2 total)
Trial APIs (3 total)